Suchergebnisse
Suchergebnisse:
Drew Weissman ist ein US-amerikanischer Immunologe an der University of Pennsylvania. Seine gemeinsam mit Katalin Karikó durchgeführten Arbeiten – insbesondere zur Nukleosid-modifizierten mRNA – gelten als grundlegend für die Entwicklung von RNA-Impfstoffen. 2023 erhielten beide den Nobelpreis für Physiologie oder Medizin.
Drew Weissman is a professor and director of vaccine research at the University of Pennsylvania. He discovered a novel nucleoside-modified mRNA platform that led to the first COVID-19 vaccines and other therapeutics.
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of ...
2. Okt. 2023 · Der Nobelpreis für Medizin geht in diesem Jahr an die 1955 in Ungarn geborene Forscherin Katalin Karikó und den 64-jährigen US-Amerikaner Drew Weissman für Grundlagen zur Entwicklung von...
- Tagesschau.De
Dr. Weissman is a Nobel laureate for his contributions to mRNA vaccine technology against COVID-19. He is also a leading expert in RNA biology, HIV immunology, and gene therapy at Penn Medicine.
Dr. Weissman is a renowned physician and researcher who invented the modified mRNA technology for COVID-19 vaccines. He and his team are also working on other mRNA vaccines and therapeutics for coronaviruses, flu, herpes, and cancer.
2. Okt. 2023 · Drew Weissman, the Roberts Family Professor of Vaccine Research at Penn, is one of the recipients of the 2023 Nobel Prize in Medicine for his work on mRNA technology. He and his partner Katalin Karikó developed the platform that enabled the rapid development of COVID-19 vaccines by Pfizer/BioNTech and Moderna.
